Agenus reports inducement grants under nasdaq listing rule 5635(c)(4)

Lexington, mass.--(business wire)--agenus inc. (“agenus”) (nasdaq: agen), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the compensation committee of agenus' board of directors granted inducement awards to eric olson, in connection with his appointment as head of regulatory. the compensation committee approved the awards pursuant to agenus' 2015 inducement equity plan and in accordance with nasdaq listing rule 5635(c)(4). the aw.
AGEN Ratings Summary
AGEN Quant Ranking